shortagewatch

Home / Systemic hormones / Triamcinolone

ATC H02AB08 · Corticosteroids for Systemic Use

Triamcinolone shortage

As of 31 Oct 2026, Triamcinolone has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Belgium), covering 24 products.

Countries4/5
Products24packs or presentations
Short since14 Nov 20197.0 years ago
Earliest return29 Nov 2026company estimate
No return date4products
Main reasonManufacturing problem
Germany19 packs shortItaly3 packs shortSpain1 pack shortAustriaNo reported shortageBelgium1 pack short

Timeline

GermanyItalySpainBelgium
20222023202420252026Triamhexal 10Triamhexal 10Triamhexal 10Triamhexal 10Triamhexal 10Triamhexal 10Triamhexal 10Triamhexal 10Triamhexal 40Triamhexal 40Triamhexal 40Triamhexal 40Triam 10mg LichtensteinTriam 10mg LichtensteinTriam 10mg LichtensteinTriam 10mg LichtensteinTriam 10mg LichtensteinTriam 10mg LichtensteinTriam 10mg LichtensteinTriam 10mg LichtensteinTriam 10mg LichtensteinTriam 10mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinTriam 40mg LichtensteinVolon A 10Volon A 10Volon A 40Volon A 40PHARMACORTPHARMACORTKENACORTKENACORTTRIACORTTRIACORTTRIGON DEPOT 40 mg/ml SUSPENSIÓN INYECTABLE,TRIGON DEPOT 40 mg/ml SUSPENSIÓN INYECTABLE, 3 viales de 1 mlKenacort-A 10 10 mg/ml inj. susp. i.derm./i.Kenacort-A 10 10 mg/ml inj. susp. i.derm./i.artic. vial 5 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DETriamhexal 10H e x a l Aktiengesellschaft24 Nov 202531 Dec 2026Manufacturing problem
Unzureichende Produktionskapazitäten
DETriamhexal 10H e x a l Aktiengesellschaft24 Nov 202531 Dec 2026Manufacturing problem
Unzureichende Produktionskapazitäten
DETriamhexal 10H e x a l Aktiengesellschaft24 Nov 202531 Dec 2026Manufacturing problem
Unzureichende Produktionskapazitäten
DETriamhexal 10H e x a l Aktiengesellschaft24 Nov 202531 Dec 2026Manufacturing problem
Unzureichende Produktionskapazitäten
DETriamhexal 40H e x a l Aktiengesellschaft26 Nov 202531 Dec 2026Manufacturing problem
Unzureichende Produktionskapazitäten
DETriamhexal 40H e x a l Aktiengesellschaft26 Nov 202531 Dec 2026Manufacturing problem
Unzureichende Produktionskapazitäten
DETriam 10mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20265 Jan 2027Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 10mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20265 Jan 2027Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 10mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20265 Jan 2027Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 10mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20265 Jan 2027Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 10mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20265 Jan 2027Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 40mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20264 Dec 2026Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 40mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20264 Dec 2026Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 40mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20264 Dec 2026Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 40mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20264 Dec 2026Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 40mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20264 Dec 2026Manufacturing problem
Probleme beim Sonstigen Hersteller
DETriam 40mg LichtensteinWinthrop Arzneimittel GmbH1 Oct 20264 Dec 2026Manufacturing problem
Probleme beim Sonstigen Hersteller
DEVolon A 10Dermapharm Aktiengesellschaft14 Oct 20266 Dec 2026Increased demand
Erhöhte Nachfrage
DEVolon A 40Dermapharm Aktiengesellschaft14 Oct 202629 Nov 2026Increased demand
Erhöhte Nachfrage
ITPHARMACORTPHARMATEX ITALIA S.R.L.14 Nov 2019not givenManufacturing problem
Problemi produttivi
ITKENACORTBRISTOL MYERS SQUIBB S.R.L.26 May 2025not givenManufacturing problem
Problemi produttivi: distribuzione contingentata (carenza relativa solo al canale retail)
ITTRIACORTPHARMATEX ITALIA S.R.L.31 Jul 2025not givenIncreased demand
Elevata richiesta/problemi produttivi
ESTRIGON DEPOT 40 mg/ml SUSPENSIÓN INYECTABLE, 3 viales de 1 mlPiramal Critical Care B.V.18 Jun 2025not givenNot stated
BEKenacort-A 10 10 mg/ml inj. susp. i.derm./i.artic. vial 5 mlBristol-Myers Squibb Belgium6 Nov 202530 Apr 2027Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Betamethasone Deflazacort Dexamethasone Hydrocortisone Methylprednisolone Prednisone